Hepatocyte integrity depends on c-Jun-controlled proliferation in Schistosoma mansoni infected mice.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 Nov 2023
Historique:
received: 14 07 2023
accepted: 16 11 2023
medline: 23 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Schistosomiasis is a parasitic disease affecting more than 250 million people worldwide. The transcription factor c-Jun, which is induced in S. mansoni infection-associated liver disease, can promote hepatocyte survival but can also trigger hepatocellular carcinogenesis. We aimed to analyze the hepatic role of c-Jun following S. mansoni infection. We adopted a hepatocyte-specific c-Jun knockout mouse model (Alb-Cre/c-Jun loxP) and analyzed liver tissue and serum samples by quantitative real-time PCR array, western blotting, immunohistochemistry, hydroxyproline quantification, and functional analyses. Hepatocyte-specific c-Jun knockout (c-Jun

Identifiants

pubmed: 37990129
doi: 10.1038/s41598-023-47646-z
pii: 10.1038/s41598-023-47646-z
pmc: PMC10663609
doi:

Substances chimiques

Cyclin D1 136601-57-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20390

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107475/Z/15/Z
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17105-10
pubmed: 17940019
Protein Cell. 2011 Nov;2(11):889-98
pubmed: 22180088
Animals (Basel). 2019 Sep 30;9(10):
pubmed: 31575048
J Histochem Cytochem. 1985 Aug;33(8):737-43
pubmed: 2410480
EMBO J. 2002 Apr 2;21(7):1782-90
pubmed: 11927562
Parasitol Res. 1989;76(2):183-4
pubmed: 2515540
Int J Infect Dis. 2014 Nov;28:193-203
pubmed: 25250908
World J Gastroenterol. 2021 Apr 28;27(16):1691-1715
pubmed: 33967551
Hepatology. 2012 Feb;55(2):408-18
pubmed: 21953113
Nat Rev Cancer. 2014 Nov;14(11):736-46
pubmed: 25342631
Cancer. 2001 Jan 1;91(1):106-12
pubmed: 11148566
Genes Dev. 2006 Aug 15;20(16):2306-14
pubmed: 16912279
Pathog Glob Health. 2022 Mar;116(2):119-127
pubmed: 34494507
Nat Rev Immunol. 2005 May;5(5):420-6
pubmed: 15864275
Oncogene. 2000 May 15;19(21):2548-56
pubmed: 10851053
Lancet Infect Dis. 2016 Aug;16(8):971-9
pubmed: 27197551
J Biol Chem. 1999 Jan 1;274(1):305-15
pubmed: 9867845
Front Immunol. 2013 Apr 15;4:89
pubmed: 23596444
Int J Parasitol. 2003 Aug;33(9):977-85
pubmed: 12906881
Mol Biochem Parasitol. 1995 May;71(2):269-72
pubmed: 7477111
Exp Mol Med. 2021 Feb;53(2):151-167
pubmed: 33558590
Travel Med Infect Dis. 2021 Nov-Dec;44:102165
pubmed: 34555514
Lab Invest. 2020 Mar;100(3):454-465
pubmed: 31570772
Cell Mol Gastroenterol Hepatol. 2023 Sep 9;17(1):107-117
pubmed: 37696392
Hepatology. 2008 Apr;47(4):1363-70
pubmed: 18366115
Hepatology. 2010 Jan;51(1):267-76
pubmed: 19827165
Cells. 2021 Aug 04;10(8):
pubmed: 34440754
FASEB J. 1995 Dec;9(15):1527-36
pubmed: 8529831
Nat Commun. 2016 Apr 18;7:11321
pubmed: 27089238
Antioxid Redox Signal. 2015 Nov 10;23(14):1144-70
pubmed: 26415143
PLoS Genet. 2020 Nov 4;16(11):e1009084
pubmed: 33147210
Biomed Res Int. 2016;2016:1567254
pubmed: 27376078
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
Nat Rev Dis Primers. 2018 Aug 9;4(1):13
pubmed: 30093684
J Cell Biol. 1999 May 31;145(5):1049-61
pubmed: 10352021
Am J Trop Med Hyg. 2017 Aug;97(2):567-574
pubmed: 28722637
Clin Chim Acta. 1967 Nov;18(2):267-73
pubmed: 4864804
Nat Rev Immunol. 2002 Jul;2(7):499-511
pubmed: 12094224
Hepatology. 2020 Aug;72(2):626-641
pubmed: 30053321
Korean J Anesthesiol. 2018 Oct;71(5):353-360
pubmed: 30157585
Cell Death Differ. 2016 Apr;23(4):576-82
pubmed: 26470729
JHEP Rep. 2022 Nov 07;5(2):100625
pubmed: 36590323
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
Front Immunol. 2018 Oct 29;9:2492
pubmed: 30459767
World J Gastroenterol. 2002 Jun;8(3):385-92
pubmed: 12046056

Auteurs

Lukas Härle (L)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Verena von Bülow (V)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Lukas Knedla (L)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Frederik Stettler (F)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Heike Müller (H)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Daniel Zahner (D)

Central Laboratory Animal Facility, Justus Liebig University Giessen, 35392, Giessen, Germany.

Simone Haeberlein (S)

Institute of Parasitology, BFS, Justus Liebig University Giessen, 35392, Giessen, Germany.

Anita Windhorst (A)

Institute of Medical Informatics, Justus Liebig University Giessen, 35392, Giessen, Germany.

Annette Tschuschner (A)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Monika Burg-Roderfeld (M)

Hochschulen Fresenius GmbH, University of Applied Sciences, 65510, Idstein, Germany.

Kernt Köhler (K)

Institute of Veterinary Pathology, Justus Liebig University Giessen, Giessen, Germany.

Christoph G Grevelding (CG)

Institute of Parasitology, BFS, Justus Liebig University Giessen, 35392, Giessen, Germany.

Elke Roeb (E)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany.

Martin Roderfeld (M)

Department of Gastroenterology, Justus Liebig University Giessen, Gaffkystr. 11c, 35392, Giessen, Germany. martin.roderfeld@innere.med.uni-giessen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH